8-89971157-C-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_002485.5(NBN):​c.702+16G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,607,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

NBN
NM_002485.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.404

Publications

1 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 8-89971157-C-G is Benign according to our data. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-89971157-C-G is described in CliVar as Benign/Likely_benign. Clinvar id is 234384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000657 (10/152228) while in subpopulation EAS AF = 0.00193 (10/5188). AF 95% confidence interval is 0.00105. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NBNNM_002485.5 linkc.702+16G>C intron_variant Intron 6 of 15 ENST00000265433.8 NP_002476.2 O60934

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NBNENST00000265433.8 linkc.702+16G>C intron_variant Intron 6 of 15 1 NM_002485.5 ENSP00000265433.4 O60934

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152110
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000188
AC:
47
AN:
249498
AF XY:
0.000178
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00251
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000153
AC:
223
AN:
1455346
Hom.:
0
Cov.:
30
AF XY:
0.000159
AC XY:
115
AN XY:
724194
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33320
American (AMR)
AF:
0.00
AC:
0
AN:
44596
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26014
East Asian (EAS)
AF:
0.00550
AC:
217
AN:
39482
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85978
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52892
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
9.03e-7
AC:
1
AN:
1107298
Other (OTH)
AF:
0.0000833
AC:
5
AN:
60058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152228
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41540
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000121

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 22, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Microcephaly, normal intelligence and immunodeficiency Benign:1
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
9.4
DANN
Benign
0.81
PhyloP100
-0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2272581; hg19: chr8-90983385; API